SVA 10月 Call 有可能涨10倍吗？

sunning

小赌怡情, 风险自负。大家觉得下面的分析结果有可能吗？
--------------------------------------------
SVA Oct 22 2011 5.0 Call may be possible to get doubled,tripled, and even 10 times at any positive news in the coming 6 months.

The current price for SVA Oct 22 2011 5.0 Call is around $0.3. It is very easy for SVA PPS to increase from the bottom $4 to $5.5 or $6 at any good news, and the call will be doubled or tripled.

If a big positive news comes in the coming 6 months(it's possible), the SVA PPS will be pushed to $8 or even $10 as two years ago, then the SVA Oct 22 2011 5.0 Call will be valued above $3 or even above $5, which will return more than 1000%, that's 10 times!

The SVA Oct 22 2011 5.0 Call may increase from $0.3 to 0.4, 0.5, and $1 pretty soon, when more people realize its big potential.

pigking

为什么会出好消息呢？

我记得这个是做感冒疫苗的。能有什么其他的新闻出来？现在不是感冒季节啊。

mengtt

sunning

pigking 发表于 2011-4-21 14:53
为什么会出好消息呢？

我记得这个是做感冒疫苗的。能有什么其他的新闻出来？现在不是感冒季节啊。

SVA 的手足口病疫苗第一期临床试验按预期应该已完成，结果可能很快发布；如果顺利，今年9月前应可完成二、三期试验。手足口病这几年在亚洲流行，没有好的预防和治疗办法。疫苗是希望。SVA 的手足口病疫苗又有可能创世界第一；

两年前，SVA首创世界第一个猪流感疫苗；

四年前，SVA首创世界第一个、也是目前惟一的禽流感疫苗。

SVA还有很多其它疫苗产品，按照WHO的标准生产。国外市场前景乐观。

SVA目前也在研究防治艾滋病和癌症的疫苗；

SVA的新疫苗结果、任何疫情消息、任何国际合作、任何国际市场的开拓都会把SVA股价推上去。

仅供参考，风险自负。

pigking

这个就有点意思了。让我看看。

sunning

- 公司今年年初新上任的主管销售的VIP将打开新的销售局面；
- SVA 的手足口病疫苗第一期临床试验按预期应该已完成，结果可能很快发布;
- $3.90-4.0应是实底，再低的可能性不大；
- 新的疫情有可能出现：
WHO H1N1 Pandemic Alert - 2009 and 2011 Recombinomics Commentary 17:30
April 26, 2011:
http://www.recombinomics.com/News/04261106/H1N1_Alert_9_11.html

仅供参考，风险自负。

sunning

What’s New?

1.
Sinovac to Host Conference Call to Report First Quarter 2011 Unaudited Financial Results
http://finance.yahoo.com/news/Si ... 3.html?x=0&.v=1

Sinovac will release its unaudited financial results for the first quarter ended March 31, 2011 before market on Friday, May 13, 2011.  The Company will host a conference call on Friday, May 13, 2011 at 8:00 a.m. EDT (March 13, 2011 at 8:00 pm China Standard Time) to review the Company's financial results and provide an update on recent corporate developments.

2.
1Q2011 earnings may include significant revenue from the govt. for H1N1 vaccine that  Sinovac had stockpiled.  Sinovac is expected to receive a big payment from the Chinese Central Government in early 2011 for its H1N1 influenza vaccine, PANFLU.1, orders by the Chinese Central Government pursuit to the government stockpiling program in early 2010.

3.
The phase 1b clinical trial results of vaccine for pneumococcal conjugate, enterovirus 71 (EV71, against Hand, Foot & Mouth Disease), would be expected for release before or during the conference call on Friday, May 13, 2011:
Phase 1a: started on 12/30/2010, completed on 2/25/2011, results released on 3/10/2011;
Phase 1b: started on 2/30/2011, completed around 4/25/2011, results may be released around 5/12-13/2011.

tjtjking

楼主那段分析是哪儿看来的？

sunning

tjtjking 发表于 2011-5-11 02:30
楼主那段分析是哪儿看来的？

一楼的只是我的遐想（瞎想），欢迎指正。